Free equity investment tool of Japanese companies

HOME >
Company List >
シンバイオ製薬 (Annual ): Financial Outline Report

Financial Outline Report: Annual; First quarter; Second quarter; Third quarter

Sponsored Link

Related Company: NIPPON SEIRO; シンバイオ製薬; Chiome Bioscience; 本州化学工業; Carna Biosciences; RaQualia Pharma; 廣貫堂; KAWAKAMI PAINT MFG.; Kawaguchi Chemical Industry; Nippon Shikizai; Sosei Group; 日本化学工業; CHISSO; 関東電化工業

EDIUNET Related Ranking: EDIUNET; EDIUNET Credit Rating; EDIUNET Industry Avg; EDIUNET Prefectures; Yuho! Industry

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

RSS

Company RSS

Daily RSS

Sponsored Link

Recently Download Chart: メルコホールディングス

ROHM

Hitachi Zosen etc.

日本セラミック etc.

日本セラミック etc.

Financial Outline Report: シンバイオ製薬 (Annual )

It is a free Financial Outline Report which can grasp intuitively a financial statement summary , a corporate value, credit rating, etc. by various charts.Two or more companies can be compared and various charts can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Summary: シンバイオ製薬 (Annual )

Credit Rating (Bankruptcy Risk) Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2012-12-31	BB	Credit is a little enough, but be insufficient potential by biz environs.	¥ 1 B 3.87%	¥ -1 B 17.47%	¥ -1 B 17.63%

Financial Timeline

Date	2012-12-31 (Annual )	2013-03-31 (First quarter )	2013-06-30 (Second quarter )	2013-09-30 (Third quarter )
Credit Rating	BB	BB	BB	BB
Total Assets	¥ 6 B	¥ 7 B	¥ 7 B	¥ 6 B
Net Assets	¥ 4 B	¥ 5 B	¥ 5 B	¥ 5 B

Net sales has increased 4 consecutive terms. The performance is good.

Net income is minus 4 consecutive terms. The business have very high risk.

Operating cash flow minus 4 consecutive terms. The business have very high risk.

Cash(¥ 4 B) is more than the total liabilities(¥ 602 M). It is a very steady fiscal base!

Financial Chart Download

Financial Timeline Chart

Financial Statement Details

Indicator Comparison Chart

Financial Indicator Details

Profitability	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Net profit margin (Industry Average)	-18.29% (-4.34%)	-44.29% (-5.37%)	-111.79% (-10.69%)	-88.64% (8.92%)
C/F margin (Industry Average)	-17.74% (1.04%)	-51.99% (0.82%)	-110.20% (-0.81%)	-84.80% (-39.63%)
ROA (Industry Average)	-5.11% (0.92%)	-15.06% (1.42%)	-28.99% (-0.27%)	-31.49% (1.53%)
ROE (Industry Average)	-5.37% (-0.46%)	-15.73% (1.81%)	-31.85% (3.42%)	-35.37% (2.62%)
Growth	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Equity growth (Industry Average)	- (3.64%)	0.72% (3.03%)	61.76% (0.04%)	-25.82% (3.91%)
Sales growth (Industry Average)	- (-)	21.73% (6.70%)	29.79% (0.75%)	3.87% (-1.74%)
Net profit growth (Industry Average)	- (166.48%)	-194.80% (43.48%)	-227.56% (-47.04%)	17.63% (62.14%)
Operating C/F growth (Industry Average)	- (89.80%)	-256.76% (77.44%)	-175.07% (-44.41%)	20.05% (46.89%)
Stability	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Capital adequacy (Industry Average)	95.14% (57.65%)	95.78% (57.17%)	91.02% (55.93%)	89.03% (57.57%)
Liquidity ratio (Industry Average)	2,054.13% (276.75%)	2,368.28% (266.94%)	1,111.64% (314.47%)	905.66% (233.84%)
C/F ratio current liabilities (Industry Average)	-97.17% (53.10%)	-23.59% (31.35%)	-31.13% (76.77%)	-36.09% (31.87%)
Quick ratio (Industry Average)	1,900.15% (183.78%)	1,304.45% (174.83%)	731.11% (228.06%)	783.27% (169.77%)
Turnover	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Receivables turnover (Industry Average)	- (98.39day)	1.49day (95.88day)	31.49day (98.58day)	27.64day (67.18day)
Inventory turnover (Industry Average)	- (48.43day)	- (47.43day)	40.23day (50.67day)	30.78day (38.21day)
Payable turnover (Industry Average)	- (51.63day)	0.29day (51.13day)	59.91day (53.57day)	61.56day (34.24day)
Working capita turnover (Industry Average)	- (95.19day)	1.19day (92.19day)	11.81day (95.69day)	-3.13day (71.15day)
Stock etc.	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Market Value growth (Industry Average)	- (34.46%)	- (3.11%)	- (-3.30%)	- (24.19%)
Dividend Yield (Industry Average)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	- (27.80%)	- (13.58%)	- (22.26%)	- (26.42%)
PBR (Industry Average)	- (1.21%)	- (1.17%)	- (1.08%)	- (1.54%)
PCFR (Industry Average)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	- (4.34%)	- (3.67%)	- (4.37%)	- (10.14%)

Corporate value chart

Enterprise Value	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Market Value	- (1)	- (1)	- (1)	- (1)
Net Value	¥ 4 B (1)	¥ 4 B (1)	¥ 6 B (1)	¥ 4 B (1)
Returns Value	¥ -2 B (- )	¥ -7 B (- )	¥ -27 B (- )	¥ -18 B (- )
Dividend Value	- (- )	- (- )	- (- )	- (- )
Enterprise Value	- (- )	- (- )	- (- )	- (- )

Related Information: シンバイオ製薬 (Annual )

Statement Type: Annual : シンバイオ製薬; First quarter : シンバイオ製薬; Second quarter : シンバイオ製薬; Third quarter : シンバイオ製薬

Analysis Menu: Outline : シンバイオ製薬; Statement : シンバイオ製薬; Rating : シンバイオ製薬; Indicator : シンバイオ製薬; Download : シンバイオ製薬

Industry Comparison Ranking: Chemicals - EDIUNET Industry Rankings; Chemicals - EDIUNET Credit Rating; Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company: Tokyo - EDIUNET Prefectures; Tokyo港区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals): 1/23 Chemicals (Milbon:AA→AAA); 1/17 Chemicals (Kawaguchi Chemica..; 1/15 Chemicals (HOKKO CHEMICAL IN..; 1/10 Chemicals (OSAKA ORGANIC CHE..; 1/9 Chemicals (SANKO GOSEI:A); 12/27 Chemicals (Niitaka:A); 12/18 Chemicals (KUMIAI CHEMICAL I..; 12/12 Chemicals (IHARA CHEMICAL IN..; 12/11 Chemicals (Konoshima Chemica..; 12/10 Chemicals (NATOCO:AA)

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

HOME >
Company List >
シンバイオ製薬 (Annual ): Financial Outline Report

EDIUNET Rating News

Screening Search

Member limited service

Company Search
- [close]
  
  [keyword]
  
  Company Search
  
  *It can search to each item of a type of industry, a stock market, the settlement-of-accounts moon, and a keyword.
  
  *Top 30 search results are displayed.
  
  [close]

Company Ranking